2023-509538-20-01RecruitingPhase 1
MAESTRO-4MS : "Allogenic Adipose tissue-derived Mesenchymal Stromal Cells for the treatment of Primary Progressive Multiple Sclerosis: an open-label phase I clinical trial."
Source: EU CTIS (euclinicaltrials.eu) · Last updated 2 Jul 2026
- Status (registry)
- Recruiting
- Phase (registry)
- Phase 1
- Study type
- Interventional
- Enrollment
- 15 (estimated)
- First submitted
- 29 Jan 2024
- Start date
- 6 Mar 2025
- Lead sponsor
- Centre Hospitalier Universitaire De Rennes
- Diseases
- Multiple sclerosis
- EU CT number
- 2023-509538-20-01
What you commit to
- Study type: Interventional · Phase 1
- Planned participants: 15
- 2 sites in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Assistance Publique Hopitaux De Paris | Creteil | France | Recruiting |
| Centre Hospitalier Universitaire de Rennes | Rennes | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.